Use of Intravenous Immunoglobulin and Rituximab for the prevention and treatment of antibody-mediated rejection

被引：0
|
作者：
Jordan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
XENOTRANSPLANTATION | 2009年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：330 / 331
页数：2
相关论文
共 50 条
  • [1] Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
    Fehr, Thomas
    Ruesi, Barbara
    Fischer, Andreas
    Hopfer, Helmut
    Wuethrich, Rudolf P.
    Gaspert, Ariana
    [J]. TRANSPLANTATION, 2009, 87 (12) : 1837 - 1841
  • [2] Rituximab and intravenous immunoglobulin treatment for chronic antibody-mediated renal allograft rejection
    Fehr, T.
    Gaspert, A.
    Ruesi-Elsener, B.
    Weber, M.
    Fischer, A.
    Wuethrich, R. P.
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [3] Treatment of Transplant Glomerulopathy during Chronic Antibody-Mediated Rejection with Intravenous Immunoglobulin and Rituximab
    Bachelet, T.
    Nodimar, C.
    Taupin, J. -L.
    Lepreux, S.
    Moreau, K.
    Morel, D.
    Guidicelli, G.
    Couzi, L.
    Merville, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 413 - 413
  • [4] IS INTRAVENOUS IMMUNOGLOBULIN AN EFFECTIVE TREATMENT FOR ACUTE ANTIBODY-MEDIATED REJECTION?
    Galloway, Lucy
    Cheng, Iek
    Dorling, Anthony
    Hilton, Rachel
    Mamode, Nizam
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 287 - 287
  • [5] Combined immunoadsorption, rituximab and intravenous immunoglobulin for the treatment of acute antibody-mediated rejection after heart transplantation
    Lyster, Haifa
    Smith, John D.
    Danskine, Anna J.
    Pottle, Alison
    Burke, Margaret
    Rose, Marlene
    Banner, Nicholas R.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 136 - 136
  • [6] RITUXIMAB, INTRAVENOUS IMMUNOGLOBULIN, PLAMAPHERESIS? HOW TREAT CHRONIC ANTIBODY-MEDIATED KIDNEY REJECTION?
    Maisin, Anne
    Macher, Marie-Alice
    Peuchmaur, Michel
    Deschenes, Georges
    Suberbielle, Caroline
    Baudouin, Veronique
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 52 - 52
  • [7] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [8] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [9] Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection With Intravenous Immunoglobulin
    Rapetskaya, Nadzeya
    Komissarov, Kirill
    Kalachyk, Aleh
    [J]. TRANSPLANTATION, 2022, 106 (09) : S572 - S572
  • [10] High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis
    Tanriover, B.
    Wright, S. E.
    Foster, S. V.
    Roush, K. S.
    Castillo-Lugo, J. A.
    Fa, K.
    Levy, F. L.
    Mejia, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (10) : 3393 - 3396
12345